Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: An epidemiological survey

World Journal of Gastroenterology

Volumn 9, Issue 5, 2003, Pages 1106-1110

  Shen, Lei ^b   Fan, Jian Gao ^a   Shao, Yan ^b   Zeng, Min De ^b   Wang, Jun Rong ^c   Luo, Guo Hao ^b   Li, Ji Qiang ^b   Chen, Si Yao ^d  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Central Hospital of Putou District   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEPATITIS B SURFACE ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADMINISTRATIVE PERSONNEL; ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINA; DIABETES MELLITUS; ECHOGRAPHY; EPIDEMIOLOGICAL DATA; FATTY LIVER; FEMALE; HEALTH SURVEY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; KIDNEY PARENCHYMA; LABORATORY TEST; LIPID BLOOD LEVEL; LIVER PARENCHYMA; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SEX DIFFERENTIATION; STATISTICAL SIGNIFICANCE;

EID: 0038544021     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i5.1106     Document Type: Article

References (53)

1. Brunt EM. Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 2001; 21: 3-16
2. Lonardo A. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Dig Dis Sci 1999; 17: 80-89
3. McCullough AJ, Falck-Ytter Y. Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 1999; 29: 1328-1330
4. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419
5. James O. Day C. Non-alcholic steatohepatitis: Another disease of affluence. Lancet 1999; 353: 1634-1636
6. Tominga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-2009
7. Yano E, Tagawa K, Yamaoka K, Mori M. Test validity of periodic liver function tests in a population of Japanese male bank employees. J Clin Epidemiol 2001; 54: 945-951
8. Powell EE, Cocksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80
9. Araujo LM, De Oliveira DA, Nunes DS. Liver and biliary ultrasonography in diabetic and non-diabetic obese women. Diabetes Metab 1998; 24: 458-462
10. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117
11. Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999; 34: 85-91
12. El-Hassan AY, Ibrahim EM, Al-Mulhim FA, Nabhan AA, Chammas MY. Fatty infiltration of the liver: Analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992; 65: 774-778
13. Joseph AE, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26-31
14. Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern. Ital J Gastroenterol Hepatol 1997; 29: 351-356
15. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001; 35: 195-199
16. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-723
17. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 1999; 30: 1356-1362
18. Flack-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalocoholic steatosis syndromes. Semin Liver Dis 2001; 21: 17-26
19. Hultcrantz R, Gabrielsson N. Patients with persistent elevation of aminotransferases: Investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 1993; 233: 7-12
20. Layer G, Zuna I, Lorenz A, Zerban H, Haberkorn U, Bannasch P, Van Kaick G, Rath U. Computerized ultrasound B-scan texture analysis of experimental diffuse parnchymal liver disease: Correlation with histopathology and tissue composition. J Clin Ultrasound 1999; 19: 193-201
21. Mendler MH, Bouillet P, LeSidaner A, Lavoine E, Labrousse F, Sautereau D, Pillegand B. Dual-energy CT in the diagnosis and quantification of fatty liver: Limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 1998; 28: 785-794
22. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517
23. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000; 45: 1929-1934
24. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438
25. Fan JG, Zeng MD, Wang GL. Pathogenesis of fatty liver. Shijie Huaren Xiaohua Zazhi 1999; 7: 75-76
26. Sabir N, Sermez Y, Kazil S, Zencir M. Correlation of abdominal fat accumulation and liver steatosis: Importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound 2001; 14: 121-128
27. Mensenkamp AR, Havekes LM, Romijn JA, Kuipers F. Hepatic steatosis and very low density lipoprotein secretion: The involvement of apolipoprotein E. J Hepatol 2001; 35: 816-822
28. Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 2001; 46: 2347-2352
29. Sharabi Y, Eldad A. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity. Am J Med 2000; 109: 171
30. Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000; 32: 3-10
31. Loguercio C, De Girolamo V, De Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, Cimino L, Di Carlo A, Di Marino MP, Morisco F, Picciotto F, Terracciano L, Vecchione R, Verde V, Del Vecchio Blanco C. Non-alcoholic fatty liver disease in an area of southern Italy: Main clinical, histological, and pathophysiological aspects. J Hepatol 2001; 35: 568-574
32. Fan JG. Steatohepatitis studies in China. Shijie Huaren Xiaohua Zazhi 2001; 9: 6-10
33. Lonardo A, Trande P. Are there any sex differnces in fatty liver? A study of glucose metabolism and body fat distribution. J Gastroenterol Hepatol 2000; 15: 775-782
34. Sonsuz A, Basaranoglu M, Bilir M, Senturk H, Akin P. Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2002; 97: 495
35. Urso R, Visco-Comandini U. Metformin in non-alcoholic steatohepatitis. Lancet 2002; 359: 355-356
36. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379
37. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35: 367-372
38. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001; 96: 2957-2961
39. Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, Conti M, Huet S, Ba N, Buffet C, Bedossa P. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 2001; 34: 738-744
40. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850
41. Sanyal AJ. Insulin resistance and nonalcoholic steatohepatitis: Fat or fiction? Am J Gastroenterol 2001; 96: 274-276
42. Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98-106
43. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455
44. Sonsuz A, Basaranoglu M, Ozbay G. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000; 95: 1370-1371
45. Lai MM. Hepatitis C virus proteins: Direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002; 122: 568-571
46. Giannini E, Ceppa P, Testa R. Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? J Hepatol 2001; 35: 432-433
47. Ong JP, Younossi ZM, Speer C, Olano A, Gramlich T, Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 2001; 21: 266-271
48. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994; 107: 1103-1109
49. Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000; 75: 733-739
50. Xu ZJ, Fan JG, Wang GL, Ding XD, Tian LY, Zheng XY. Rat model of nonalcoholic steatohepatitis with fibrosis by a fat-rich diet. Shijie Huaren Xiaohua Zazhi 2002; 10: 392-396
51. Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: Present and emerging therapies. Semin Liver Dis 2001; 21: 81-88
52. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27-41
53. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 1999; 282: 1659-1664